- 期刊
- OpenAccess
Comorbidity Profile Among Patients with Rheumatoid Arthritis and the Impact on Prescriptions Trend
並列摘要
Comorbid conditions play a pivotal role in rheumatoid arthritis management and outcomes. We estimated the percentage of comorbid illness among rheumatoid arthritis patients and explored the relationship between this comorbidity and different prescriptions. A cross-sectional study of patients with rheumatoid arthritis in three centers in Saudi Arabia was carried out. Comorbidity and antirheumatoid medication regimens prescribed were recorded on a specially designed Performa. The association between comorbidity and different drugs was analyzed. A total of 340 patients were included. The most comorbidities were hypertension 122 (35.9%), diabetes 105 (30.9%), osteoporosis 88 (25.8%), and dyslipidemia in 66 (19.4). The most common drug prescribed was prednisolone in 275 (80.8%) patients followed by methotrexate in 253 (74.4%) and biological therapy in 142 (41.5%) patients. Glucocorticoids were prescribed considerably more frequently in hypertensive and diabetic patients as well as in patients with osteoporosis and dyslipidemia. Most patients with rheumatoid arthritis suffered from comorbid diseases.
延伸閱讀
- 胡淑娥（2005）。The relationship of cognitive features, coping, and adaptation in rheumatoid arthritis patients〔碩士論文，中原大學〕。華藝線上圖書館。https://doi.org/10.6840/cycu200500734
- Tzeng, G. S., Chang, D. M., Kuo, S. Y., & Chang, M. L. (1995). Mortality in Rheumatoid Arthritis. Formosan Journal of Rheumatology, 12(3&4), 29-37. https://doi.org/10.6313/FJR.199512_12(3_4).0004
- Wang, S. T., Lu, M. C., Koo, M., Huang, K. Y., Tung, C. H., & Lai, N. S. (2018). Conventional Lipid Profiles and Its Relation to Inflammatory Markers in Patients with Rheumatoid Arthritis. Formosan Journal of Rheumatology, 32(1), 1-9. https://doi.org/10.6313/FJR.201809_32(1).0001
- Cerezo, L. A., Kuklová, M., Hulejová, H., Vernerová, Z., Kasplíková, N., Veigl, D., Pavelka, K., Vencovský, J., & Senolt, L. (2015). Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. Mediators of Inflammation, 2015(), 829-834-385. https://doi.org/10.1155/2015/740357
- Haga, H. J., Moreno, A. M., Andersen, D. T., & Peen, E. (2014). Serum-Prolactin and the Association to Disease Activity in Patients with Rheumatoid Arthritis. Research in Endocrinology, 2014(), h1-6. https://doi.org/10.5171/2014.396352